Capricor Therapeutics

Graphic image of a red thumbs down against a blue background

Biotech

FDA rejects Capricor’s DMD cell therapy, asks for more data

The rejection raises questions about whether the new-look FDA leadership may be rowing back from some of the flexibility shown by the old regime.

Nick Paul Taylor Jul 11, 2025 9:18am

Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

BMS oncology head swings to Syndax—Chutes & Ladders

May 16, 2025 8:30am

Duchenne muscular dystrophy DMD

Capricor shares turn red as FDA announces deramiocel adcomm plan

May 6, 2025 8:32am

Blue race track

Capricor shares more data for DMD therapy after initiating BLA

Oct 11, 2024 11:50am

pay deal hand over cash licensing transaction money

Capricor sells Europe rights to late-stage DMD therapy for $35M

Sep 18, 2024 5:55am

traffic light green light

Capricor culls COVID-19 vax work, readies for phase 3 DMD trial

Mar 11, 2022 8:00am